Precision Diagnostic Imaging (PDI) is our region’s PET/CT centre. The team at PDI recognizes that PET will have a profound impact on the diagnosis and treatment of many diseases and is committed to making PET/CT clinically available for patients in our community. PDI is one of three Ministry approved Independent Health Facilities in Ontario. Dr. Tracey is the Medical Director of the PDI clinic and thanks to his determination and commitment to improving imaging services in our region, our patients now have access to this superior diagnostic tool that helps improve treatment and save lives. No longer do patients have to go out of town or across the border to access PET scans. Finally, patients in our region have convenient and cost effective access to this highly valued and precise diagnostic tool for more effective detection of diseases such as cancer, heart and neurological disorders.
PET scans provide physicians and surgeons with a life-saving answer to the following questions/concerns:
• Does my patient have cancer?
• Has my patient’s cancer spread?
• Has my patient’s cancer come back?
PET is now considered the gold standard for cancer diagnosis and is an extremely effective new tool in the fight against disease.
PET Accuracy Chart
The Ontario government has established a set of criteria to guide the OHIP coverage of PET scans for patients who qualify. Patients who do not qualify under this OHIP criteria may be covered under the Ontario PET Registry Program or the Ontario PET Access program. Patients who do not qualify under any of these programs may opt to pay for this service either at PDI, other Ontario PET centres or in the United States.
PDI, which is located at 2462 Howard Avenue, operates a state-of-the-art mobile GE Discovery PET/CT scanner provided by Alliance Imaging, a leading US provider of advanced outpatient diagnostic imaging services. Alliance was the first national provider of diagnostic imaging services to be awarded accreditation by The Joint Commission.
This state-of-the-art mobile unit includes oncology and cardiac software as well as a dosing facility and patient waiting area.
About OHIP Coverage for PET/CT
To qualify for OHIP coverage a patient must fulfill one of the following criteria:
• Solitary pulmonary nodule which could not be established by a needle biopsy
• Non-small cell lung cancer where curative surgical resection is being considered
• Clinical stage III non-small lung cancer where potentially curative combined modality therapy with radical radiotherapy and chemotherapy is being considered
Limited disease small cell lung cancer where combined modality therapy with chemotherapy and radiotherapy is being considered
• Thyroid cancer where recurrent or persistent disease is suspected on the basis of an elevated and/or rising thyroglobulin but standard imaging studies are negative or equivocal
• Germ cell tumours where recurrent disease is suspected on the basis of elevated tumour markers and standard imaging tests are negative or a mass persists after primary treatment for seminoma and curative surgical resection is being considered
• Colorectal cancer where recurrent disease is suspected on the basis of an elevated and/or rising carcinoembryonic antigen level during follow-up after surgical resection but standard imaging tests are negative or equivocal
• Lymphoma for the evaluation of residual mass following chemotherapy in a patient with Hodgkin’s or non-Hodgkin’s lymphoma when further potentially curative therapy is being considered or for the assessment of response in early stage Hodgkin’s lymphoma following two or three cycles of chemotherapy.
About Ontario PET Registry
However, if the type of PET/CT scan a patient requires is not on the approved OHIP list, the scan may still be obtained through Ontario’s PET Registry.
The indications that are eligible for reimbursement through the Ontario PET Registry are:
• Esophageal cancer for the staging of patients who are being considered for potentially curative therapy
• Pancreatic cancer for staging if the patient is a candidate for potentially curative surgical resection
• Melanoma for the staging of melanoma patients with localized “high risk” tumours with potentially resectable disease
• Testicular cancer for the assessment of completeness of responses in patients with seminoma and residual mass(es) after chemotherapy/radiotherapy and biopsy is not possible or is inconclusive.
About PET Access
The Ontario PET Access program has been set up for patients who do not qualify under OHIP or under the PET Registry’s criteria. The PET access program considers, on a case by case basis, requests from physicians for access to PET scans for patients who may benefit, but who do not fit the criteria to receive PET scans under insured services, clinical trials or the PET Registry. A panel of experts considers each request and makes recommendations about funding.
If a patient is denied under the PET Access program that patient still has the option of paying for the service either at PDI or in the U.S. At PDI the cost for this service is $2,500 CDN and may be reduced depending on the patient’s circumstances. Each patient is evaluated on a case by case basis. It is important to note that the cost of the dose of FDG required to perform the scan is $800.
Patient Referral Process
To refer your patient for a PET/CT scan simply complete a referral form and forward it to PDI Regional PET/CT Centre by fax: 519.252.5000 or email: firstname.lastname@example.org
About the PDI Facility
PDI, which is located at 2462 Howard Avenue, operates a state-of-the-art mobile GE Discovery 8 slice PET/CT scanner provided by a leading US supplier of advanced outpatient diagnostic imaging services. This mobile unit includes oncology and cardiac software as well as a dosing facility and patient waiting area.
For more information CONTACT DR. TRACEY